BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 33904678)

  • 1. Distribution of Myeloid and Plasmacytoid Dendritic Cell Subpopulations in Peripheral Blood of Hyperprolactinemic Women.
    Raeesi Nejad F; Mohammadi MM; Sanjari M; Malkpour Afshar R; Jafari E
    Iran J Allergy Asthma Immunol; 2021 Apr; 20(2):198-204. PubMed ID: 33904678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral blood dendritic cells in human end-stage heart failure and the early post-transplant period: evidence for systemic Th1 immune responses.
    Athanassopoulos P; Vaessen LM; Maat AP; Balk AH; Weimar W; Bogers AJ
    Eur J Cardiothorac Surg; 2004 Apr; 25(4):619-26. PubMed ID: 15037281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [An increased prevalence of thyroid echographic and autoimmune changes in hyperprolactinemic women on therapy with dopaminergic drugs].
    Giusti M; Foppiani L; Fazzuoli L; Molinari E; Guido R; Valenti S; Giordano G
    Recenti Prog Med; 1999 Mar; 90(3):147-51. PubMed ID: 10228354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperprolactinemia is associated with a high prevalence of serum autoantibodies, high levels of inflammatory cytokines and an abnormal distribution of peripheral B-cell subsets.
    Liu Y; Zhang Z; Jin Q; Liu Y; Kang Z; Huo Y; He Z; Feng X; Yin J; Wu X; Wang H; Xu H
    Endocrine; 2019 Jun; 64(3):648-656. PubMed ID: 30887277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered diurnal rhythm of prolactin in systemic sclerosis.
    Hilty C; Brühlmann P; Sprott H; Gay RE; Michel BA; Gay S; Neidhart M
    J Rheumatol; 2000 Sep; 27(9):2160-5. PubMed ID: 10990228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased thyroid-stimulating hormone response to thyrotropin-releasing hormone in hyperprolactinemic women.
    Seki K; Kato K
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1138-41. PubMed ID: 3932450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid autoimmunity in patients with hyperprolactinemia: an observational study.
    Onal ED; Saglam F; Sacikara M; Ersoy R; Cakir B
    Arq Bras Endocrinol Metabol; 2014 Feb; 58(1):48-52. PubMed ID: 24728164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequencies of dendritic cells (myeloid DC and plasmacytoid DC) and their ratio reduced in pregnant women: comparison with umbilical cord blood and normal healthy adults.
    Ueda Y; Hagihara M; Okamoto A; Higuchi A; Tanabe A; Hirabayashi K; Izumi S; Makino T; Kato S; Hotta T
    Hum Immunol; 2003 Dec; 64(12):1144-51. PubMed ID: 14630396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Frequency of increased thyrotropin in women with hyperprolactinemia].
    Carranza-Lira S; Daza-Carrasco ML; Chán-Verdugo R
    Rev Med Inst Mex Seguro Soc; 2017; 55 Suppl 1():S53-S57. PubMed ID: 28212475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ontogenesis of human fetal hormones. III. Prolactin.
    Aubert MJ; Grumbach MM; Kaplan SL
    J Clin Invest; 1975 Jul; 56(1):155-64. PubMed ID: 1141430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in dendritic cells and dendritic cell subpopulations in peripheral blood of recipients during acute rejection after kidney transplantation.
    Ma L; Liu Y; Wu J; Xu X; Liu F; Feng L; Xie Z; Tang Y; Sun W; Guo H; Zhang L; Lin J; Tian Y
    Chin Med J (Engl); 2014; 127(8):1469-73. PubMed ID: 24762591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Investigation of plasmacytoid dendritic cell reconstitution and its relationship with cGVHD and relapse after haploidentical hematopoietic stem cell transplantation].
    Wu JY; Huang XJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):342-7. PubMed ID: 17493344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reconstitution dynamics of plasmacytoid and myeloid dendritic cell precursors after allogeneic HLA mismatched/ haploidentical hematopoietic stem cell transplantation].
    Wu JY; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2007 Feb; 28(2):73-7. PubMed ID: 17650664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in peripheral dendritic cells in serious burn patients and its clinical significance].
    Liu Q; Lu JY; Wang XH; Zhang Z
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2011 Nov; 23(11):678-80. PubMed ID: 22093314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced dopaminergic inhibition of thyrotropin release in hyperprolactinemic ovulatory women.
    Larrea F; Escorza A; Valencia X; Méndez I; Schiavon R; Forsbach G
    Rev Invest Clin; 1991; 43(4):293-8. PubMed ID: 1798861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary autonomy in hyperprolactinemic secondary amenorrhea: results of hypothalamic-pituitary testing.
    Healy DL; Pepperell RJ; Stockdale J; Bremner WJ; Burger HG
    J Clin Endocrinol Metab; 1977 May; 44(5):809-19. PubMed ID: 404308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of nonarticular tenderness and prevalence of fibromyalgia in hyperprolactinemic women.
    Buskila D; Fefer P; Harman-Boehm I; Press J; Neumann L; Lunenfeld E; Gedalia A; Potashnik G; Sukenik S
    J Rheumatol; 1993 Dec; 20(12):2112-5. PubMed ID: 8014940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Identification and enumeration of dendritic cells in peripheral blood and bone marrow of healthy individuals].
    Wang DX; Lin HR; Wang YZ; Chang Y; Hao L; Liu YR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1255-60. PubMed ID: 19840462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catecholamines and pituitary function. III. Restoration of the prolactin response to thyrotropin-releasing hormone by low-dose dopamine infusion in women with pathological hyperprolactinemia.
    Nicoletti I; Filipponi P; Fedeli L; Sfrappini M; Gregorini G; Ambrosi F; Santeusanio F
    Horm Res; 1984; 20(3):202-12. PubMed ID: 6436160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloid dendritic cells correlate with clinical response whereas plasmacytoid dendritic cells impact autoantibody development in rheumatoid arthritis patients treated with infliximab.
    Richez C; Schaeverbeke T; Dumoulin C; Dehais J; Moreau JF; Blanco P
    Arthritis Res Ther; 2009; 11(3):R100. PubMed ID: 19563672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.